1. Potent and PPARα-independent anti-proliferative action of the hypolipidemic drug fenofibrate in VEGF-dependent angiosarcomas in vitro
   Yasser Majeed et al, 2019, Scientific Reports CrossRef
2. Intravasation of SW620 colon cancer cell spheroids through the blood endothelial barrier is inhibited by clinical drugs and flavonoids in vitro
   Silvio Holzner et al, 2018, Food and Chemical Toxicology CrossRef
3. Resistance to antiangiogenic treatments: A review
   Tomas Koltai et al, 2022, Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy CrossRef
4. Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges
   Alina L. Capatina et al, 2020, Targets of Cancer Diagnosis and Treatment CrossRef
5. Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro
   Junli Hong et al, 2018, Frontiers in Pharmacology CrossRef
6. The emerging role of PPAR-alpha in breast cancer
   Zhiwen Qian et al, 2023, Biomedicine & Pharmacotherapy CrossRef
7. 12(S)-HETE induces lymph endothelial cell retraction in�vitro by upregulation of SOX18
   Adryan Fristiohady et al, 2018, International Journal of Oncology CrossRef